awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28477868-BFBEE32B-718F-4E26-BC41-419B733A8031
Q28477868-BFBEE32B-718F-4E26-BC41-419B733A8031
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28477868-BFBEE32B-718F-4E26-BC41-419B733A8031
Evaluation of the efficacy and safety of rivaroxaban using a computer model for blood coagulation
P2860
Q28477868-BFBEE32B-718F-4E26-BC41-419B733A8031
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28477868-BFBEE32B-718F-4E26-BC41-419B733A8031
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
37ed4828d11bff7ab5d9c9d82d1cdd3fe0a10e42
P2860
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.